Exagen announces appointment of john aballi as ceo

San diego, oct. 17, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), announced today that the company has appointed john aballi as ceo and president.  longtime ceo and president ron rocca, who took the company public and built a robust growth business, is stepping down after 11 years at the helm.
XGN Ratings Summary
XGN Quant Ranking